EGPA is characterised by prominent infiltration of eosinophils, through a Th2 cytokine-mediated mechanism involving elevated IL-4, IL-5 and IL-13 levels and eosinophilia. The gene discussed is IL5; the disease is eosinophilic granulomatosis with polyangiitis.